| Record ID | marc_records_scriblio_net/part15.dat:39134292:1281 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part15.dat:39134292:1281?format=raw |
LEADER: 01281cam 22003857a 4500
001 2004270241
003 DLC
005 20040622134111.0
008 040324s2003 nyua b 001 0 eng d
010 $a 2004270241
040 $aNLM$cNLM$dYEH$dCUI$dOCLCQ$dDLC
016 7 $a101183133$2DNLM
020 $a0824740262 (alk. paper)
035 $a(OCoLC)ocm52362556
042 $alccopycat
050 00 $aRM301.28$b.B566 2003
082 00 $a615/.19$222
060 00 $aW1$bDR893B v.132 2003
060 10 $aQV 744$bB6153 2003
245 00 $aBiomarkers in clinical drug development /$cedited by John C. Bloom and Robert A. Dean.
260 $aNew York :$bMarcel Dekker,$cc2003.
300 $aviii, 295 p. :$bill. ;$c24 cm.
440 0 $aDrugs and the pharmaceutical sciences ;$vv. 132
504 $aIncludes bibliographical references and index.
650 0 $aClinical pharmacoplogy.
650 0 $aPharmaceutical technology.
650 0 $aBiochemical markers.
650 0 $aDrugs$xTesting.
650 12 $aDrug Design.
650 22 $aBiological Markers.
650 22 $aDrug Evaluation$xmethods.
650 22 $aTechnology, Pharmaceutical.
700 1 $aBloom, John C.
700 1 $aDean, Robert Allen.
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/fy045/2004270241.html